Cargando…

Targeting the YAP/TAZ mechanotransducers in solid tumour therapeutics

Detalles Bibliográficos
Autores principales:	Gargalionis, Antonios N., Papavassiliou, Kostas A., Papavassiliou, Athanasios G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315712/ https://www.ncbi.nlm.nih.gov/pubmed/37226849 http://dx.doi.org/10.1111/jcmm.17794

Ejemplares similares

Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Implication of mTOR Signaling in NSCLC: Mechanisms and Therapeutic Perspectives
por: Gargalionis, Antonios N., et al.
Publicado: (2023)

Targeting STAT3 Signaling Pathway in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2021)

Polycystins, mechanotransduction and cancer development
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)
por: Papavassiliou, Kostas A., et al.
Publicado: (2022)

Mechanosignalling in tumour progression
por: Gargalionis, Antonios N., et al.
Publicado: (2017)

mTOR Signaling Components in Tumor Mechanobiology
por: Gargalionis, Antonios N., et al.
Publicado: (2022)

Polycystin‐1 and hydrostatic pressure are implicated in glioblastoma pathogenesis in vitro
por: Zoi, Ilianna, et al.
Publicado: (2022)

Polycystins and mechanotransduction in bone
por: Gargalionis, Antonios N., et al.
Publicado: (2017)

Polycystins in Colorectal Cancer
por: Gargalionis, Antonios N., et al.
Publicado: (2018)

Polycystins and Mechanotransduction in Human Disease
por: Gargalionis, Antonios N., et al.
Publicado: (2019)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Polycystin‐1 affects cancer cell behaviour and interacts with mTOR and Jak signalling pathways in cancer cell lines
por: Papavassiliou, Kostas A., et al.
Publicado: (2019)

Polycystin‐1 modulates RUNX2 activation and osteocalcin gene expression via ERK signalling in a human craniosynostosis cell model
por: Katsianou, Maira, et al.
Publicado: (2021)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Combining STAT3-Targeting Agents with Immune Checkpoint Inhibitors in NSCLC
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Polycystin‐1 regulates cell proliferation and migration through AKT/mTORC2 pathway in a human craniosynostosis cell model
por: Katsianou, Maria A., et al.
Publicado: (2022)

The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity
por: Markouli, Mariam, et al.
Publicado: (2021)

Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID‐19?
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Defective Anti-oxidant System: An Aggravating Factor for COVID-19 Patients Outcome?
por: Kassi, Eva N., et al.
Publicado: (2020)

G6PD and chloroquine: Selecting the treatment against SARS‐CoV‐2?
por: Kassi, Eva N., et al.
Publicado: (2020)

YAP and TAZ are dispensable for physiological and malignant haematopoiesis
por: Donato, Elisa, et al.
Publicado: (2018)

Lung Cancer through Transcription Factors
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
por: Piperi, Christina, et al.
Publicado: (2019)

Vistas in Non-Small Cell Lung Cancer (NSCLC) Treatment: of Kinome and Signaling Networks
por: Stravopodis, Dimitrios J., et al.
Publicado: (2023)

The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
por: Cunningham, Richard, et al.
Publicado: (2022)

Non-secreting pituitary tumours characterised by enhanced expression of YAP/TAZ
por: Xekouki, Paraskevi, et al.
Publicado: (2018)

YAP1/TAZ drives ependymoma-like tumour formation in mice
por: Eder, Noreen, et al.
Publicado: (2020)

Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis
por: Markouli, Mariam, et al.
Publicado: (2022)

Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
por: Brouwer, Niels J., et al.
Publicado: (2021)

YAP and TAZ regulate cell volume
por: Perez-Gonzalez, Nicolas A., et al.
Publicado: (2019)

YAP/TAZ Activation as a Target for Treating Metastatic Cancer
por: Warren, Janine S. A., et al.
Publicado: (2018)

Solid Cancers and Rheumatoid Arthritis
por: Kalliolias, George D., et al.
Publicado: (2023)

Nuclear Import and Export of YAP and TAZ
por: Kofler, Michael, et al.
Publicado: (2023)

DNA binding partners of YAP/TAZ
por: Kim, Min-Kyu, et al.
Publicado: (2018)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Mechanisms of YAP/TAZ transcriptional control
por: Battilana, Giusy, et al.
Publicado: (2021)

YAP/TAZ in Bone and Cartilage Biology
por: Zarka, Mylène, et al.
Publicado: (2022)

YAP/TAZ dull the STING of aging
por: Francisco, Jamie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qjl3ofn0gsoovmead11lo8l36j